Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Medicine Mindmed Inc
(NQ:
MNMD
)
6.655
+0.065 (+0.99%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mind Medicine Mindmed Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
27
28
Next >
Psychedelic Stock Gainers And Losers From December 2, 2022
December 02, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 1, 2022
December 01, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022
November 30, 2022
Via
Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 29, 2022
Via
Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
November 28, 2022
Via
Benzinga
7 F-Rated Stocks to Sell Before We Reach Christmas
November 28, 2022
While you’re looking for the perfect holiday bargains, this is also an ideal time to clear your portfolio from F-rated stocks to sell.
Via
InvestorPlace
Mind Medicine’s Bad Trip Won’t End Anytime Soon
November 04, 2022
Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board.
Via
InvestorPlace
Psychedelic Stock Gainers And Losers From November 25, 2022
November 25, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
November 24, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
November 23, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
November 22, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
Via
Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
November 20, 2022
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...
Via
Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
Via
Benzinga
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
November 15, 2022
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics
Via
Benzinga
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
November 14, 2022
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Upgrades
Via
Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
November 11, 2022
Clinical-stage biotech company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results and updated on its programs pipeline of the third quarter ended September 30, 2022.
Via
Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
November 10, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 09, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14
Via
Benzinga
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
November 07, 2022
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.
Via
Talk Markets
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27
Via
Benzinga
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
November 03, 2022
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis...
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:
Via
Benzinga
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
October 28, 2022
While penny stocks are highly speculative and risky, you may still want to consider these seven opportunities.
Via
InvestorPlace
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.